Innovation Spotlight
Rapid Diagnostics: R² System & Portfolio
The R² Rapid Response System serves as a culture-free universal diagnostic engine. Providing species-level identification and exact pathogen counts directly from blood, urine, or tissue in just 3 hours, it stays entirely resilient to human DNA interference without requiring complex extraction steps.
In addition to the core system, Dr. Vishu Asthana’s portfolio features standalone technologies designed to enhance sample prep and target detection:
- Customizable Stackable Sample Filters: 3D-printed, stackable filter devices that clear background sample "junk" and isolate target bacteria for clinical, agricultural, and pharma labs.
- High-Multiplexing PCR Primers: High-multiplexing universal primer sets engineered to expand diagnostic coverage from standard limits (5–10 targets) up to 100+ targets in a single run.
Learn more about Dr. Vishu Asthana’s research impact below, featuring his startup Pyogenics and pitch competition wins.
For more information on research collaboration, direct IP licensing please contact [email protected].
